GlassScriptPhysician profile
Reynaldo Godines
NPI 1659457406
$1,936.48
in general payments reported to CMS, 2019-2025
19 companies · $21.60 in 2025
The $21.60 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $142 · 2021: $282 · 2022: $272 · 2023: $536 · 2024: $323 · 2025: $21.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.21 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $335.82 | 2022-2025 | Terlivaz |
| Intercept Pharmaceuticals, INC. | $235.44 | 2019-2022 | |
| Boston Scientific Corporation | $178.00 | 2022-2024 | Exalt Model D, Spyglass, Agile Esophageal |
| Evoke Pharma, INC. | $141.07 | 2020-2022 | |
| Bolton Medical INC | $130.12 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Eisai INC. | $116.49 | 2019 | |
| Melinta Therapeutics, LLC | $113.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $107.82 | 2023 | |
| Nestle Healthcare Nutrition INC. | $106.17 | 2020-2023 | |
| Sonex Health, INC. | $105.02 | 2023 | Sx-One Microknife |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.84 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $68.70 | 2022 | |
| Amag Pharmaceuticals, INC. | $64.06 | 2021 | |
| Alexion Pharmaceuticals, INC. | $40.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.28 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $29.65 | 2024 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $22.04 | 2024 | Voquezna |
| Celgene Corporation | $14.53 | 2023 | Zeposia |
| Olympus America INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reynaldo Godines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.